POLA2 inhibitors represent a class of chemical compounds that specifically target and inhibit the function of the POLA2 protein. POLA2, short for DNA polymerase alpha subunit B, plays a pivotal role in DNA replication, a fundamental process crucial for the maintenance of genomic integrity and the propagation of genetic information during cell division. Within the cellular DNA replication machinery, POLA2 forms a heterotetrameric complex with POLA1 (DNA polymerase alpha catalytic subunit) and the primase, PRIM1. This complex functions as the DNA polymerase alpha-primase complex and is responsible for initiating the synthesis of DNA strands during replication. In this context, POLA2 serves as a critical cofactor that interacts with POLA1, facilitating the efficient synthesis of short RNA-DNA primers required to initiate DNA replication. POLA2 inhibitors are designed to disrupt this essential interaction and, by extension, impair the normal progression of DNA replication.
The mechanism of action of POLA2 inhibitors typically involves the binding of these compounds to specific regions of POLA2 or its associated proteins, thereby inhibiting the formation of the functional POLA1-POLA2-PRIM1 complex. By doing so, these inhibitors hinder the initiation of DNA synthesis, leading to the accumulation of single-stranded DNA breaks, replication stress, and for genomic instability. Additionally, interference with POLA2's role in DNA replication may also have downstream effects on cell cycle progression and DNA repair mechanisms. As such, POLA2 inhibitors are valuable tools for studying the intricacies of DNA replication and its regulation in cellular contexts, shedding light on the fundamental processes underlying genome maintenance. Researchers utilize these inhibitors in laboratory settings to elucidate the molecular details of DNA replication and explore vulnerabilities that could be exploited for various scientific investigations beyond their applications.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Selective estrogen receptor modulator (SERM) inhibiting estrogen binding to its receptor, preventing gene transcription. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Tyrosine kinase inhibitor targeting BCR-ABL fusion protein and c-Kit, inhibiting downstream signaling. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Epidermal growth factor receptor (EGFR) inhibitor blocking the EGFR kinase domain. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multikinase inhibitor targeting RAF kinase and VEGFR, inhibiting tumor cell proliferation and angiogenesis. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK1/JAK2 inhibitor blocking signaling pathways involved in cytokine-mediated inflammation. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
EGFR tyrosine kinase inhibitor inhibitng autophosphorylation and downstream signaling. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Dual EGFR/HER2 inhibitor, blocking phosphorylation of both receptors. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, inhibitng cell cycle progression in cancer cells. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor disrupting protein degradation and inducing apoptosis in cancer cells. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
BCL-2 inhibitor disrupting anti-apoptotic signaling in leukemia cells. | ||||||